Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

PCNE Working Symposium 2014, Sliema, Malta

Medication review, Drug-related problems, Standards and Guidelines

14-15 March 2014


Dear friends,Kurt Hersberger

The Pharmaceutical Care Network Europe is an active association, with three working groups

  • Medication Review
  • Drug Related Problems
  • Standards and Guidelines

In order to advance the work of the Working Groups, they must meet regularly. Therefore we have organised this Working Symposium in Malta in 2014, where non-members also were welcome.

In the wonderful setting of this old island, we presented and discussed the recent developments in all three fields, suggested to adapt classifications, declarations and definitions. We had a wonderful seaside hotel for this event.

After two days of working group meetings, we also had a General Assembly of the Association where we welcomed new applicants for membership. During tea and coffee breaks, participants could exchange information about their activities.

The slides of the lectures and reports of the meetings of the Working Groups will gradually appear. Please see under the tab 'Workshops' above, for the reports of the sessions.

Prof. Dr. Kurt Hersberger,
PCNE Chairman
Basle, Switzerland

Sponsor

PCNE welcomed SPINGER Science and Business Media and Hilary Cordina as valued sponsors.

Springer logo

Conference committee, organisation and contact

Conference committee: Charlotte Rossing, Denmark; Nina Griese, Germany; Veerle Foulon, Belgium; Foppe van Mil, the Netherlands; Kurt Hersberger, Switzerland (Chair). 
Organisation: Maria Cordina (Malta) and Foppe van Mil (Professional Secretary PCNE) 
Contact: info@pcne.org
Abstract review committee: Prof. K. Hersberger, Dr. N. Griese-Mammen, Dr. V. Foulon, Dr. C. Rossing, Dr. M. Cordina

  

Workshops

All sesions (on DRPs, Medication Review, and Pharmaceutical Care Guidelines and Standards) consisted of a number of lectures, plus workshops.

Workshops Drug-related problems program 

(Friday 14th March Morning)

1. The PCNE-DRP classification for beginners

In this workshops the participants will learn how the classification works, what the domains, and options for use are, and how to score drug-related problems with the help of the classification V6.2. (Facilitator: Arijana Meštrović)

2. The PCNE-DRP classification for experienced users

In this workshop the participants will complete a set of cases for validation purposed. The scoringand the system V 6.2will then be evaluated with the participants. (Facilitators: Markus Messerli and Samuel Alleman)

3. Improving thePCNE-DRP classification V6.2

This workshop is for more-or less exprienced users of the classification, and will try to evaluate the current version as an aid to future improvements for a version 7 (or 6.3). (Facilitator: Foppe van Mil)

4. Validating a Drug-related problem classification

This workshop is for experience researchers. Participants will discuss which elements of a DRP classification need validation, and what would be the best methods to carry out this validation. (Facilitators: Kurt Hersberger, Carole Kaufmann, Karen Maes)

Workshops Medication review program 

(Friday 14th March afternoon)

Click here to download the program report >>

1. PCNE milestones for medication review

This workshop is for PCNE members and participants who intend to become a member. Participants will discuss what they as a member expect from PCNE with regard to medication review and its  further development. (Facilitator: Martin Henman)

2. Finalizing the PCNE definition of medication review

This workshop is for participants who have been already involved in PCNE medication review workshops and discussions. PCNE has held several workshops and symposia on the topic. During these workshops and symposia a definition was developed. The participants will discuss the PCNE definition of medication review with the aim of finalization this definition for PCNE statements . (Facilitator: Nina Griese and Kurt Hersberger)

3. DRP and medication review: Which DRP can be detected with level I and 2a 

This workshop is both for beginners and for experienced researchers. On the basis the results of the PCNE workshop Berlin and the PCNE-DRP classification the participants will complete a list of DRP that can be detected with these levels.(Facilitator: Saija Leikola)

4. DRP and medication review: Which DRP can be detected with level 2b

This workshop is both for beginners and for experienced researchers. On the basis the results of the PCNE workshop in Berlin and the PCNE-DRP classification the participants will complete a list of DRP that can be detected with these levels. 
(Facilitator: Markus Messerli and Lea Botermann)

Workshops Standards and Guideline program 

(Saturday 15th March, 13-16.00h)

A World Café! Participants will be divided into smaller groups to discuss the different roles PCNE could take in the future work concerning guidelines and standards, and to start this work.
Themes for the different groups:
   - Writing disease-specific guidelines
   - Writing guidelines on processes
   - Developing methodology to achieve valid guidelines

Program

Friday 14th March 2014

8.00-9.00 Registration
9.00-9.15 Opening (Prof. Kurt Hersberger)
9.15-13.00 Drug Related Problems (Dr. Foppe van Mil & Markus Messerli, chairs)
9.15-9.30 The PCNE-DRP classification, history and projects (Foppe van Mil, the Netherlands)
9.30-9.45 Using the PCNEclassification in Belgium (Dr. Isabelle de Wulf, Belgium) - Abstract
9.45-10.00 Using the PCNE classification in Continuing Professional Development (Dr. Arijana Mestrovic, Croatia) - Abstract
10.00-10.15 Creating and validating a DRP classification. (Ms. Karen Maes, Switzerland) - Abstract
10.15-11.00 Workshops & group-discussions on Drug-related problem classifications [Part 1]. See the tab 'Workshops'.
11.00-11.30 Coffee break and Posters
11.30-12.30 Workshops & group-discussions on Drug-related problem classifications [Continued]. 
12.30-13.00 Workshop reports and closure

13.00-14.00 Lunch and posters

14.00-18.00 PCNE and medication review (Dr. Nina Griese & Saija Leikola, chairs)

14:00 – 14:10 Introduction (Nina Griese, Germany)
14:10 – 14:30 PCNE definition of medication review and the achievements of the Berlin working conference (Saija Leikola, Finland)
14:30 – 14:50 Exploratory study of pharmacist-led home medication use reviews (HMUR) for elderly people in collaboration with family doctors and home care nurses (Olivier Bugnon, Switzerland)
14:50 – 15:10 Implementation and evaluation of a new multidisciplinary guideline on polypharmacy in the Netherlands (Menno van Woerkom, Netherlands) - Abstract
15:10 – 15:30 GeriMed, a medication review programme for nursing homes (Manfred Krüger, Germany)
15:30 – 15:50 Medication review - focus inappropriate medications - for the elderly patients in an intermediate care unit in primary care (Kirsten Viktil, Norway)

15:50 – 16:00 Introduction: topics of working groups
16:00 – 16:30 Tea break and posters
16:30 – 17:30 Discussion in smaller groups

17:30 – 18:00 Presentation of results and discussion
18.00-18.30 Wrap-up of day one Prof. Kurt Hersberger)

Dinner at participants’ expenses (and choice)

Saturday 15th March 2014

The purpose of the day is to get an overview on the work that has been done regarding the development of pharmaceutical care guidelines and standards, and to debate the different approaches PCNE could take to this work.

9 - 9.15 Welcome and outline of the purpose of the day
9.15 – 12.00 Examples and Country cases
- Guidelines for general pharmaceutical services and for chronic diseases (Dr. Berry Daemen, the Netherlands)- Abstract
- The case of “Inhalation Check Technique” (Dr. Charlotte Rossing, Denmark) - Presentation
- Belgium: Veerle Foulon: A methodological perspective (Dr. Veerle Foulon, Belgium) - Presentation
- EDQM indicators on Pharmaceutical Care (Dr. Dick Tromp, president Europharm Forum) - Presentation

12.00 -13.00 Lunch and posters

13.00-16.00 Debate (see tab Workshops)
16.00-16.30 Workshop reports & plenary discussion, including concusions on future work for PCNE

16.30-18.30 Members soapbox (new): An exchange of PCNE members projects and publications (PCNE members only)

Dinner

19.30 Departure to PCNE anniversary dinner by bus (transfer included in fee)
20.00- ........ ? PCNE anniversary dinner (20 years, separate registration, fully booked)

Sunday 16th March 2013

9.00-13.00 PCNE General Assembly (members only) incl. coffee break

Abstracts

Accepted and presented abstracts are published in the International Journal of Clinical Pharmacy in 2014 after the Symposium.

List of accepted abstracts (click on the title to see the abstract)

ID Title Scope Country Organization

1437

Omission Impossible; A Snapshot of Medication Dose Omissions in an Australian Teaching Hospital

DRP

Australia

The University of Western Australia

1438

Improving the management of anaphylaxis in the community: are action plans the key?

Guidelines

Australia

The University of Western Australia

1439

Prescribing of benzodiazepines for insomnia and behavioural and psychological symptoms of dementia in residential aged care facilities

Guidelines

Australia

The University of Western Australia

1444

Home medicines review in the elderly

Medication Review

Portugal

ISCSEM

1445

Drug relation problems in Polish patients with chronic illness.

DRP

Poland

Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University, Krakow, POLAND

1446

Prevalence of inappropriate prescribing of inhaled corticosteroids for respiratory tract infections in the Netherlands

Guidelines

Netherlands

KNMP Den Haag, RadboudUMC Nijmegen

1447

Pharmacist Involvement to Decrease Drug Related Problem (DRP) among Geriatric Patients in Indonesian Primary Health Centers

DRP

Other

Governmental Health Office in District Karanganyar, Central Java Province, Indonesia

1448

Evaluation of a Danish pharmacist student-physician medication review collaboration model

Medication Review

Denmark

Department of Pharmacy, Faculty of Health and Medical Science, University of Copenhagen

1449

Patient adherence to antihypertensives in Slovenia

Medication Review

Slovenia

Chair of Social Pharmacy, University of Ljubljana- Faculty of pharmacy

1450

Development of shared care guidelines in rheumatology

Guidelines

Malta

Department of Pharmacy, University of Malta

1451

When skills are not enough – Home Medication Reviews (HMRs) seen through tutors´, pharmacy students´ and GPs´ competency glasses.

Medication Review

Denmark

Copenhagen University, Denmark

1452

Evolution of Pharmaceutical Care definitions: The PCNE definition 2013

Guidelines

Switzerland

University of Basel, Switzerland

1453

Risks in pharmacist prescribing guidelines

Guidelines

Malta

Department of Pharmacy, University of Malta

1454

Should the first step in a medication review - the medication reconciliation – be performed by nurses or by pharmacists?

Medication Review

Norway

Hospital Pharmacy of North Norway, Tromsø, Norway

1455

Potential DRP related to computerized physician order entry: an updating of DRP classifications needed

DRP

Spain

Pharmacy Department-Hospital del Mar, Barcelona, Spain

1456

Medication Use Review Service in Qatar: A Nationwide Study on Knowledge, Attitudes and Practices of Community Pharmacists

Medication Review

Other

Pharmacy & Drug Control Department, Supreme Council of Health, Doha-Qatar

1457

Clinical medication reviews in a naturalistic setting: drug-related problems identified in the elderly with polypharmacy

Medication Review

Netherlands

VU University Medical Center, Department of Clinical Pharmacology

1458

Identification of pharmaceutical care needs for a sample population of rheumatoid arthritis patients on methotrexate

DRP

Malta

Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta

1459

Development and validation of medication assessment tools specific for rheumatoid arthritis

Guidelines

Malta

Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta

1460

Validation and adaptation of The PCNE Classification V 6.2 for use in Slovenian community pharmacies

DRP

Slovenia

Chair of Social Pharmacy, University of Ljubljana- Faculty of pharmacy

1461

Classification for pharmaceutical interventions in patient oriented care: a new concept

DRP

Switzerland

Pharmaceutical Care Research Group, University of Basel, Switzerland

1463

Evaluation of drug related problems in Belgium : focus on corticosteroids

DRP

Belgium

Laboratory of Pharmaceutics and Biopharmaceutics, Faculté de Pharmacie, Université Libre de Bruxelle

1464

Evaluation of a drug related problem classification tool in community pharmacy daily practice

DRP

Belgium

Laboratory of Pharmaceutics and Biopharmaceutics, Faculté de Pharmacie, Université Libre de Bruxelle

1465

Development of the PCNE standards for medication reviews

Medication Review

Switzerland

Pharmaceutical Care Research Group, University of Basel, Switzerland

1466

The analysis of drug-related problems identified by the Polish community pharmacists participating in PCAHD (Pharmaceutical Care in Arterial Hypertension and Diabetes) Project

DRP

Poland

Department of Social Pharmacy, Jagiellonian University Collegium Medicum, Krakow, Poland

1467

National pharmacy practice standards and evidence based guidelines in pharmaceutical care; development and methodology in Hungary. 

Guidelines

Hungary

University of Szeged, Faculty of Pharmacy, Institute of Drug Regulatory Affairs

 

 

The conference is closed. You can not send in abstracts anymore.

Picturebook